NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
AAX BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AAX BIOTECH
ST13
US500000079422804Class
1, 5, 42
Filing
79422804
Registration
8330051
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
07/07/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/12/2025
Registration date
07/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
64
Owner location
SE
Examiner
FOUTS, KAREN JEANNE SEPUR
Law office
O70
Current location
TMO LAW OFFICE 134
Holders and representatives
Holders
AAX Biotech AB
Representatives
Jonathan Pearce SoCal IP Law Group LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibody reagents for scientific purposes for the detection of antigens in cells and tissueother than for medical or veterinary purposes; monoclonal antibody reagentsother than for medical use
Class 5
Antibodies for medical or veterinary purposes
Class 42
Scientific researchdevelopmentengineeringlaboratorytesting services in the field of biochemistry and biotechnology; researchdevelopmentengineeringtestingconsultinglaboratoryanalytical services in the field of antibody technology and novel antibody therapeutics; researchengineeringtestingconsultinglaboratoryanalytical services relating to the development and production of monoclonal antibodies; research and development of antibodiestherapeuticsvaccinesimmunotherapiesdiagnostics being diagnostic preparations; research services in the field of immune repertoire analysispersonalised medicinevaccinesimmunotherapiesdiagnostics being diagnostic preparations and related consultation services; researchdevelopmentengineeringtestingconsultinglaboratoryanalytical services in the field of drug discovery and drug screening for scientific research purposes; scientific and technological servicesscientific researchanalysis and testing in the field of biochemistry and biotechnology and research and design relating thereto; industrial analysis and research services in the field of biochemistry and biotechnology
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2026
PUBO
PUBLISHED FOR OPPOSITION
05/19/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2026
RFNT
REFUSAL PROCESSED BY IB
10/18/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/01/2025
RFRR
REFUSAL PROCESSED BY MPU
09/30/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/14/2025
CNRT
NON-FINAL ACTION WRITTEN
08/13/2025
DOCK
ASSIGNED TO EXAMINER
08/12/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/01/2025
Continuous trademark protection
Get notified about every new filing that threatens AAX BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.